Related Experiment Video
Updated: May 26, 2025
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Cardiac phenotypes in LMNA mutations
1Center for Cardiovascular Genetics, Institute of Molecular Medicine and Department of Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas, USA.
Insights
LMNA mutations cause diverse heart conditions like dilated cardiomyopathy (DCM) and arrhythmias by affecting nuclear stability. Personalized care and targeted therapies are key for managing these complex genetic heart diseases.
Area of Science:
- Cardiovascular Medicine
- Molecular Genetics
- Cell Biology
Background:
- Mutations in the LMNA gene are linked to a spectrum of inherited cardiac conditions.
- Understanding the molecular basis of these mutations is crucial for diagnosis and treatment.
Purpose of the Study:
- To review the diverse cardiac manifestations associated with LMNA mutations.
- To explore the underlying molecular mechanisms and clinical implications of these mutations.
- To highlight the importance of understanding these phenotypes for advancing patient care.
Main Methods:
- Review of recent scientific literature on LMNA mutations and cardiac phenotypes.
- Analysis of findings from mouse models elucidating disease pathways.
- Examination of advances in genetic screening and risk stratification.
Main Results:
- LMNA mutations disrupt nuclear envelope stability, triggering DNA damage response and affecting chromatin organization and mechanotransduction.
- Dysfunctional LMNA pathways contribute to cardiac fibrosis, arrhythmias, and myocardial remodeling, with fibroblasts playing a significant role.
- Genetic screening advances emphasize early identification and risk stratification for arrhythmias and sudden cardiac death.
Conclusions:
- The wide range of LMNA-related cardiac phenotypes necessitates personalized treatment strategies.
- Integrating molecular and clinical research insights can lead to targeted therapies to improve patient outcomes.
- Future research should focus on translational studies of molecular mechanisms, genotype-phenotype correlations, and refining therapeutic interventions.
Purpose Of Review:
This review highlights the diverse cardiac manifestations of LMNA mutations, focusing on their underlying molecular mechanisms and clinical implications. As LMNA mutations are implicated in cardiomyopathies, such as dilated cardiomyopathy (DCM), arrhythmogenic cardiomyopathy (ARVC), and conduction system diseases, understanding these phenotypes is critical for advancing diagnosis and management strategies.
Recent Findings:
Recent studies reveal that LMNA mutations disrupt nuclear envelope stability, activating the DNA damage response (DDR) and compromising chromatin organization and mechanotransduction. Mouse models have elucidated pathways linking LMNA dysfunction to fibrosis, arrhythmias, and myocardial remodeling. Emerging evidence demonstrates that fibroblasts play a crucial role in cardiac phenotypes. Advances in genetic screening have also underscored the importance of early identification and risk stratification, particularly for arrhythmias and sudden cardiac death.
Summary:
The diverse spectrum of LMNA-related cardiac phenotypes, from isolated conduction defects to severe DCM and ARVC, underscores the necessity of personalized care strategies. Bridging insights from molecular studies and clinical research paves the way for targeted therapies to slow disease progression and improve patient outcomes. Future efforts should prioritize translational research on molecular mechanisms with potential in mouse models, alongside a deeper exploration of genotype-phenotype correlations, to refine and implement effective therapeutic interventions.
